Yotam Levin is President and Co Founder of NanoPass, a commercial-stage, clinical innovation company, working to improve vaccines and aesthetics using a novel injection device. The device is the first of its kind to ever register with the FDA, EMEA, and CFDA.
NanoPass commercialized the device in 30 countries and conducted/supported 70 clinical trials all over the world with big pharma, biotech, NIH and others. Yotam received his MD and MBA from Tel Aviv University. In his spare time, Yotam runs, treks (group and solo), volunteers (Variety, Otef) and teaches healthcare entrepreneurship. His areas of expertise relate to vaccine development, drug and vaccine delivery and development and drug-device combinations, and his areas of self-education include longevity biology and immunotherapy.